X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

What symbol and exchange does X4 Pharmaceuticals shares trade?

X4 Pharmaceuticals trades on the NASDAQ stock market under the symbol XFOR.

What is X4 Pharmaceuticals stock price doing today?

As of October 28, 2026, XFOR stock price climbed to $3.35 with 516,983 million shares trading.

What is X4 Pharmaceuticals's Beta?

XFOR has a beta of 1.87, meaning it tends to be more sensitive to market movements. XFOR has a correlation of 0.11 to the broad based SPY ETF.

How much is X4 Pharmaceuticals worth?

XFOR has a market cap of $332.14 million. This is considered a Small Cap stock.

How much money does X4 Pharmaceuticals make?

Last quarter X4 Pharmaceuticals reported $9 million in Revenue and -$.13 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.06.

What is the highest and lowest price X4 Pharmaceuticals traded in the last 3 year period?

In the last 3 years, XFOR traded as high as $48.00 and as low as $1.35.

What are the top ETFs holding X4 Pharmaceuticals?

The top ETF exchange traded funds that XFOR belongs to (by Net Assets): VTI, IWM, IWN, VXF, VTWO.

Is X4 Pharmaceuticals (XFOR) a good investment?

XFOR has underperformed the market in the last year with a return of -10.4%, while the SPY ETF gained +13.8%. In the last 3 month period, XFOR fell short of the market, returning -15.0%, while SPY returned +4.8%. However, in the most recent 2 weeks XFOR has outperformed the stock market by returning +28.8%, while SPY returned -0.7%.

What are the support and resistance levels for X4 Pharmaceuticals (XFOR)?

XFOR support price is $3.10 and resistance is $3.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XFOR shares will trade within this expected range on the day.